The South & Central America influenza vaccines market is expected to grow from US$ 497.54 million in 2022 to US$ 736.35 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2022 to 2028.
Below are a few more instances supporting the government support for influenza vaccination: In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination is driving the South & Central America influenza vaccines market.
Increase in Government Support to Promote Influenza Vaccination
The governing bodies of various states and countries are supporting the promotion of vaccination through multiple activities and programs. By 2022, enough vaccines have been secured to cover all risk groups eligible for a government-funded flu vaccine through the NIP.Below are a few more instances supporting the government support for influenza vaccination: In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination is driving the South & Central America influenza vaccines market.
Market Overview
The South & Central America influenza vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market for influenza vaccines in the region is expected to experience growth opportunities during the forecast period. The influenza vaccines market in SAM is expected to grow owing to factors such as an increase in cases of influenza in the region, surge in various research activities in the region, rise in health awareness, and an increase in healthcare expenditure by the countries of the region.South & Central America Influenza Vaccines Market Segmentation
The South & Central America influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.- Based on vaccine type, the South & Central America influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.
- Based on virus type, the South & Central America influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.
- Based on technology, the South & Central America influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.
- Based on route of administration, the South & Central America influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.
- Based on target group, the South & Central America influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.
- Based on country, the South & Central America influenza vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market in 2022.
Table of Contents
1. Introduction1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Influenza Vaccines Market - By Vaccine Type
1.3.2 South & Central America Influenza Vaccines Market - By Virus Type
1.3.3 South & Central America Influenza Vaccines Market - By Technology
1.3.4 South & Central America Influenza Vaccines Market - By Route of Administration
1.3.5 South & Central America Influenza Vaccines Market - By Target Group
1.3.6 South & Central America Influenza Vaccines Market - By Country
2. South & Central America Influenza Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Influenza Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America PEST Analysis
4.3 Experts Opinion
5. South & Central America Influenza Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market - South & Central America Analysis
6.1 South & Central America Influenza Vaccines Market, By Country - Forecasts And Analysis
6.2 South & Central America Influenza Vaccines Market Revenue Forecasts And Analysis
6.2.1 South & Central America : Influenza Vaccines Market, 2019-2028 (US$ Million)
7. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type
7.1 Overview
7.2 South & Central America Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.2.1 South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Quadrivalent Vaccines : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Trivalent Vaccines : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type
8.1 Overview
8.2 South & Central America Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.2.1 South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Influenza Virus Type A : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Influenza Virus Type B : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology
9.1 Overview
9.2 South & Central America Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.2.1 South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
9.3 Egg-based
9.3.1 Overview
9.3.2 Egg-based : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
9.4.1 Overview
9.4.2 Cell-Based : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration
10.1 Overview
10.2 South & Central America Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.3 Injection
10.3.1 Overview
10.3.2 Injection : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Nasal Spray: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group
11.1 Overview
11.2 South & Central America Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.2.1 South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
11.3 Infants
11.3.1 Overview
11.3.2 Infants : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
11.4.1 Overview
11.4.2 Children: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
11.5.1 Overview
11.5.2 Adults : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
11.6.1 Overview
11.6.2 Elderly People: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
12. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - Country Analysis
12.1 South and Central America Influenza Vaccine Market Revenue and Forecasts To 2028
12.1.1 Overview
12.1.3 South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
12.1.3.1 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.3.1.1 Overview
12.1.3.1.2 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.3.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
12.1.3.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
12.1.3.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
12.1.3.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
12.1.3.1.7 Brazil: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.3.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.3.2.1 Overview
12.1.3.2.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.3.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
12.1.3.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
12.1.3.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
12.1.3.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
12.1.3.2.7 Argentina: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.3.3 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.3.3.1 Overview
12.1.3.3.2 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.3.3.3 Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
12.1.3.3.4 Rest of South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
12.1.3.3.5 Rest of South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
12.1.3.3.6 Rest of South and Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
12.1.3.3.7 Rest of South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
13. South & Central America Influenza Vaccine Market -Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 SEQIRUS
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sanofi
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Mitsubishi Chemical Group Corporation
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Serum Institute of India Pvt. Ltd
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 MYLAN N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
Table 1. Below are a few instances of companies and their pipeline products:
Table 2. South & Central America Influenza Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
Table 3. South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 4. South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 5. South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 6. South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Brazil: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 9. Brazil: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 10. Brazil: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 11. Brazil Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 12. Argentina: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 13. Argentina: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 14. Argentina: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 15. Argentina: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 16. Argentina Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of South and Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 22. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 23. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 24. Glossary of Terms, Influenza Vaccines Market
Figure 1. South & Central America Influenza Vaccines Market Segmentation
Figure 2. South & Central America Influenza Vaccines Market Segmentation, by Country
Figure 3. South & Central America Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in South & Central America Influenza Vaccines Market
Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South and Central America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. South & Central America Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 9. South & Central America Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 10. Quadrivalent Vaccines: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Trivalent Vaccines: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. South & Central America Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 13. Influenza Virus Type A : Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Influenza Virus Type B: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. South & Central America Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 16. Egg-based: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Cell-Based: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. South & Central America Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 19. Injection: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Nasal Spray: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. South & Central America Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 22. Infants : South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Children: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Adults: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Elderly People: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. South and Central America: Influenza Vaccine Market, by Key Country - Revenue (2022) (USD Million)
Figure 27. South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 28. Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Growth Strategies in the Influenza Vaccine Market, 2021-2028
Companies Mentioned
- AstraZeneca
- GlaxoSmithKline plc.
- Mitsubishi Chemical Group Corporation
- MYLAN N.V.
- Sanofi
- SEQIRUS
- Serum Institute of India Pvt. Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 132 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 497.54 Million |
| Forecasted Market Value ( USD | $ 736.35 Million |
| Compound Annual Growth Rate | 6.8% |
| No. of Companies Mentioned | 7 |
